According to a recent LinkedIn post from Brevel Ltd, the company has been awarded a grant of close to $1 million from the Israel Innovation Authority. The post indicates that the funding is intended to enable Brevel to open its illuminated fermentation platform to external users.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights planned access for other microalgae strains, plant cell cultures, and additional biomanufacturing applications on its platform. The post suggests that Brevel aims to position itself as a scale-up engine for next-generation biomanufacturing, potentially creating new revenue streams through platform-based services.
From an investor perspective, the reported grant could strengthen Brevel’s balance sheet and reduce near-term financing pressure for technology development. Association with the Israel Innovation Authority may also signal a degree of third-party validation for Brevel’s technology and its relevance to climate-tech and industrial biotech markets.
If Brevel can successfully attract other companies to build on its fermentation platform, this may support higher utilization of its infrastructure and improve operating leverage over time. The move could also diversify the company’s customer base beyond its own microalgae products, which may enhance long-term growth prospects and industry positioning in biomanufacturing.